Gilead Sciences Inc GILD:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:52 PM EDT
73.52quote price arrow up+0.26 (+0.35%)
Volume
2,587,875
Close
73.26quote price arrow down-0.43 (-0.58%)
Volume
4,343,570
52 week range
71.37 - 87.86
Loading...
  • Open73.69
  • Day High74.17
  • Day Low73.21
  • Prev Close73.69
  • 52 Week High87.86
  • 52 Week High Date01/19/24
  • 52 Week Low71.37
  • 52 Week Low Date02/16/24

Key Stats

  • Market Cap91.265B
  • Shares Out1.25B
  • 10 Day Average Volume8.04M
  • Dividend3.08
  • Dividend Yield4.20%
  • Beta0.20
  • YTD % Change-9.57

KEY STATS

  • Open73.69
  • Day High74.17
  • Day Low73.21
  • Prev Close73.69
  • 52 Week High87.86
  • 52 Week High Date01/19/24
  • 52 Week Low71.37
  • 52 Week Low Date02/16/24
  • Market Cap91.265B
  • Shares Out1.25B
  • 10 Day Average Volume8.04M
  • Dividend3.08
  • Dividend Yield4.20%
  • Beta0.20
  • YTD % Change-9.57

RATIOS/PROFITABILITY

  • EPS (TTM)4.50
  • P/E (TTM)16.26
  • Fwd P/E (NTM)10.32
  • EBITDA (TTM)10.351B
  • ROE (TTM)25.70%
  • Revenue (TTM)27.116B
  • Gross Margin (TTM)76.04%
  • Net Margin (TTM)20.69%
  • Debt To Equity (MRQ)109.43%

EVENTS

  • Earnings Date04/25/2024(est)
  • Ex Div Date03/14/2024
  • Div Amount0.77
  • Split Date-
  • Split Factor-

Latest On Gilead Sciences Inc

Profile

MORE
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. Its product categories include HIV, COVID-19, Viral Hepatitis, Oncology and others. Under HIV, it offers Biktarvy, Genvoya, Descovy, Odefsey, Complera /Eviplera, Truvada, Stribild and Sunlenca. Its Veklury (remdesivir) is a...
Daniel O'Day
Chairman of the Board, Chief Executive Officer
Andrew Dickinson
Chief Financial Officer
Flavius Martin M.D.
Executive Vice President - Research
Stacey Ma Ph.D.
Executive Vice President - Pharmaceutical Development and Manufacturing
Deborah Telman
Executive Vice President - Corporate Affairs, General Counsel, Corporate Secretary
Address
333 LAKESIDE DR
Foster City, CA
94404
United States

Top Peers

SYMBOLLASTCHG%CHG
GSK
GSK plc
42.14-0.05-0.12%
AMGN
Amgen Inc
270.90+2.03+0.76%
VRTX
Vertex Pharmaceuticals Inc
411.38+3.69+0.91%
ZTS
Zoetis Inc
170.69-1.88-1.09%
BMY
Bristol-Myers Squibb Co
51.59-0.75-1.43%